Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

6.640 -0.050 (-0.75%)
Streaming Delayed Price Updated: 3:15 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
30 31 Next >
News headline image
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic... 
Via Talk Markets
News headline image
A Comparison Of 5 Psychedelic ETFs And Indices ↗
A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector. 
Via Talk Markets
News headline image
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
Via Benzinga
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 8, 2022 ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
Via Benzinga
News headline image
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript ↗
CMPS earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Compass Pathways: Q3 Earnings Insights ↗
Compass Pathways (NASDAQ:CMPS) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
The Psychedelic Drug Stocks Index Continued To Plummet Last Week ↗
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
News headline image
Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
Via Benzinga
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗
(Part four of a four-part series) See previous stories in this series:  
Via Benzinga
News headline image
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights ↗
Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 3, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
Via Benzinga
News headline image
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S. ↗
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis... 
Via Benzinga
News headline image
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
From COMPASS Pathways
Via GlobeNewswire
News headline image
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
Via Benzinga
News headline image
Compass Pathways's Earnings Outlook ↗
Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Compass... 
Via Benzinga
News headline image
Why Shares of atai Life Sciences Climbed 14.58% on Tuesday ↗
The company specializes in developing psychedelics as therapies. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities ↗
(Part one of a four-part series) 
Via Benzinga
News headline image
15 Global Psychedelics Executives To Keep An Eye On In 2022 ↗
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list... 
Via Benzinga
News headline image
October Recap: Major Psychedelic Drug Stocks Declined 9.9% ↗
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD. 
Via Talk Markets
News headline image
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 25, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39 
Via Benzinga
News headline image
Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week ↗
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since... 
Via Talk Markets
News headline image
Major Psychedelic Stock Downward Trend Continues ↗
The 8 constituents of our Psychedelic Drug Stocks Index continue to collectively show poor performance, down 4.6% more last week and now down 45.5% since the end of August. 
Via Talk Markets
News headline image
Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 18, 2022 ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 17, 2022 ↗
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52 
Via Benzinga
News headline image
Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More ↗
Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.